Cargando…
Clinical Aspergillus Signatures in COPD and Bronchiectasis
Pulmonary mycoses remain a global threat, causing significant morbidity and mortality. Patients with airways disease, including COPD and bronchiectasis, are at increased risks of pulmonary mycoses and its associated complications. Frequent use of antibiotics and corticosteroids coupled with impaired...
Autores principales: | Tiew, Pei Yee, Thng, Kai Xian, Chotirmall, Sanjay H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146266/ https://www.ncbi.nlm.nih.gov/pubmed/35628736 http://dx.doi.org/10.3390/jof8050480 |
Ejemplares similares
-
Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
por: Tiew, Pei Yee, et al.
Publicado: (2023) -
The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
por: Tiew, Pei Yee, et al.
Publicado: (2020) -
Applying Next-Generation Sequencing and Multi-Omics in Chronic Obstructive Pulmonary Disease
por: Tiew, Pei Yee, et al.
Publicado: (2023) -
Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
por: Schäfer, Jürgen, et al.
Publicado: (2018) -
Bronchiectasis: an emerging global epidemic
por: Chotirmall, Sanjay H., et al.
Publicado: (2018)